Clinical trial
A Study Examining the Use of a Migraine Medicine in the Treatment of Two…
NCT00203268 · Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00203268 |
|---|---|
| Title | A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity |
| Official title | An Open Label Pilot Trial to Collect and Evaluate Data on the Use of Dihydroergotamine Mesylate in the Treatment of Two Migraine Attacks Associated With Cutaneous Allodynia |
| Lead sponsor | Thomas Jefferson University, Other |
| Collaborators | Bausch Health Americas, Inc. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | dihydroergotamine mesylate |
| Enrollment | 13 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Jun 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: